Marimed (MRMD) Payables (2011 - 2026)

Marimed (MRMD) has reported Payables for 16 consecutive years, with $16.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payables rose 13.17% year-over-year to $16.6 million in Q2 2026; TTM through Jun 2026 was $16.6 million, a 13.17% increase from a year earlier, with the FY2025 full-year figure at $17.1 million, down 6.42% from the prior year.
• Payables was $16.6 million for Q2 2026 at Marimed, down from $18.4 million in the prior quarter.
• Over five years, Payables peaked at $18.8 million in Q1 2025 and troughed at $4.7 million in Q1 2023.
• A 5-year average of $12.6 million and a median of $12.4 million in 2024 frame the typical range for Payables.
• Across the five-year window, Payables sank 43.73% in 2023 and soared 141.63% in 2024, its largest moves.
• Over 5 years, Payables stood at $10.4 million in 2022, then slipped by 6.5% to $9.7 million in 2023, then soared by 88.35% to $18.3 million in 2024, then dropped by 6.42% to $17.1 million in 2025, then fell by 3.35% to $16.6 million in 2026.
• The last three Payables figures came in at $16.6 million (Q2 2026), $18.4 million (Q1 2026), and $17.1 million (Q4 2025), per Business Quant data.